Company intelligence / Profile preview
Zhejiang Huahai Pharmaceutical Co., Ltd.
Linhai, Zhejiang Province, Chinahuahaipharm.com ↗
- Ownership
- Private
- Employees
- ~8221
- Development stage
- Phase 3
01
Overview
The company has over 10 products in clinical research stages, including an IL-36R monoclonal antibody for generalized pustular psoriasis in Phase III trials, an IL-17A monoclonal antibody in clinical trials, and a PD-L1/VEGF dual antibody in Phase II trials showing positive efficacy signals in treating multiple cancers.
- Therapeutic areas
- OncologyDermatologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small moleculesBiologics (monoclonal antibodies)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Over 800 cooperative partners
Beyond the preview
Go deeper on Zhejiang Huahai Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhejiang Huahai Pharmaceutical Co., Ltd..